Atlas Trials

Phase I to Test a New Pneumococcal Vaccine

Clinical trial NCT03303976 · COMPLETED

Trial details

NCT number
NCT03303976
Sponsor
LimmaTech Biologics AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pneumococcal PneumoniaPneumonia, Bacterial
Start date
2017-09-07
Primary completion
2018-09-12
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.